Robert J. Lefkowitz, Keshava Rajagopal, Erin J. Whalen  Molecular Cell 

Slides:



Advertisements
Similar presentations
Figure 1 Signalling pathways involved in muscle wasting in heart failure Figure 1 | Signalling pathways involved in muscle wasting in heart failure. Pathways.
Advertisements

IRS-1: Auditing the effectiveness of mTOR inhibitors
HuD Stimulates Translation via eIF4A
RNase E Finds Some sRNAs Stimulating
Translational Homeostasis via eIF4E and 4E-BP1
Parallel Parkin: Cdc20 Takes a New Partner
CHIPping Away at Base Excision Repair
Endocytosis Conducts the Cell Signaling Orchestra
Deconstructing ERK Signaling in Tumorigenesis
Methed-Up FOXOs Can't In-Akt-ivate
PINK1 and Parkin Flag Miro to Direct Mitochondrial Traffic
Identification of TOR Signaling Complexes
The Two Faces of Receptor Interacting Protein Kinase-1
Volume 142, Issue 4, Pages (August 2010)
A New Link in the Chain from Amino Acids to mTORC1 Activation
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Triggering Selective Autophagy at the Right Place and the Right Time
The Role of Smads in Skin Development
Proteaphagy—Selective Autophagy of Inactive Proteasomes
Hedgehog Signaling: Is Smo a G Protein-Coupled Receptor?
Volume 46, Issue 5, Pages (June 2012)
The CULt of Caspase-8 Ubiquitination
DePFth Perception in Clathrin-Mediated Endocytosis
PAF Makes It EZ(H2) for β-Catenin Transactivation
Eukaryotic Transcription Activation: Right on Target
IRS-1: Auditing the effectiveness of mTOR inhibitors
Myosin Learns to Recruit AMPA Receptors
Double Repression in Jasmonate-Mediated Plant Defense
Lucas T. Gray, Alan M. Weiner  Molecular Cell 
Connecting Mitochondria and Innate Immunity
Volume 15, Issue 3, Pages (March 2014)
Chemokines and leukocyte trafficking in rheumatoid arthritis
Beyond Red Hair and Sunburns: Uncovering the Molecular Mechanisms of MC1R Signaling and Repair of UV-Induced DNA Damage  Pamela B. Cassidy, Zalfa A. Abdel-Malek,
Keeping Transcriptional Activators under Control
14-3-3ζ Turns TGF-β to the Dark Side
γHV68 vGAT: A Viral Pseudoenzyme Pimping for PAMPs
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
T Cells Are Smad’ly in Love with Galectin-9
Silencing Insulin Resistance through SIRT1
TIGIT and CD226: Tipping the Balance between Costimulatory and Coinhibitory Molecules to Augment the Cancer Immunotherapy Toolkit  Kristen E. Pauken,
Insulin Action under Arrestin
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Finding the Right Partner: Science or ART?
Intracellular Toll-like Receptors
Volume 19, Issue 5, Pages (September 2005)
DUB-le Trouble for Cell Survival
Linking Inflammasome Activation and Phagosome Maturation
CAMTA in Cardiac Hypertrophy
Death in the CNS: Six-Microns-Under
Volume 88, Issue 4, Pages (November 2015)
Angelman Syndrome: Finding the Lost Arc
The Expanding Cosmos of Nuclear Receptor Coactivators
Inflammation NODs to Antagonists of RIP2-XIAP Interaction
Immune Signaling by RIG-I-like Receptors
aMAGEing New Players Enter the RING to Promote Ubiquitylation
Volume 8, Issue 1, Pages (July 2010)
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Shared Principles in NF-κB Signaling
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Eric N. Johnson, PhD, Kirk M. Druey, MD 
Kannanganattu V. Prasanth  Molecular Cell 
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
The TRIP from ULF to ARF Cancer Cell
S-Nitrosylation at the Interface of Autophagy and Disease
Conformational Ensembles in GPCR Activation
A new key in breast cancer metastasis
Gankyrin: An intriguing name for a novel regulator of p53 and RB
PTEN and p53: Who will get the upper hand?
53BP1 Goes Back to Its p53 Roots
Presentation transcript:

New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors  Robert J. Lefkowitz, Keshava Rajagopal, Erin J. Whalen  Molecular Cell  Volume 24, Issue 5, Pages 643-652 (December 2006) DOI: 10.1016/j.molcel.2006.11.007 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Model of Inactive and Active Conformations of β-Arrestin2 The inactive conformation of β-arrestin2 displaying an intact polar core at the junction of N and C domains with the C tail in close proximity to the junction. Activation of β-arrestin2 via interaction with the phosphorylated tail of an activated receptor promotes the disruption of the polar core and allows for release of the C tail, exposing both clathrin and AP2-binding domains. (Model is adapted from Xiao et al. [2004].) Molecular Cell 2006 24, 643-652DOI: (10.1016/j.molcel.2006.11.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 β-Arrestins at the Crossroads of Ubiquitination and Receptor Signaling (1) MDM2 binds and ubiquitinates receptor-associated β-arrestin, promoting clathrin and AP2 recruitment, receptor internalization, and β-arrestin-mediated signaling. (2) β-arrestins facilitate receptor ubiquitination, serving as adaptors to bring E3 ligases into proximity with the receptors, thereby promoting receptor trafficking to lysosomes for degradation. (3) β-arrestin1 serves as an adaptor to bring the E3 ligase MDM2 to the activated IGF-1 receptor, thereby promoting receptor ubiquitination and subsequent proteasomal degradation. (4) β-arrestins compete with IRS-1 for MDM2, thereby decreasing insulin-induced MDM2-mediated ubiquitination and proteasomal degradation of IRS-1. β-arrestins thus enhance insulin sensitivity. (5) Insulin stimulation promotes β-arrestin phosphorylation, ubiquitination, and downregulation, thereby increasing 7TMR-mediated G protein signaling and decreasing β-arrestin-mediated signaling, e.g., to ERK. (6) In Drosophila melanogaster, the nonvisual arrestin homolog Kurtz interacts with the ubiquitin ligase Deltex to facilitate Notch ubiquitination. Notch ubiquitination promotes its proteasomal degradation. Molecular Cell 2006 24, 643-652DOI: (10.1016/j.molcel.2006.11.007) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Conventional versus Biased Seven-Transmembrane Receptor Signaling (A) Agonist-stimulated 7TMR signaling via both heterotrimeric G proteins and β-arrestins. (B) Conventional antagonists bind 7TMRs and prevent agonist stimulated signaling through both heterotrimeric G proteins and β-arrestins. (C) Biased antagonists/agonists (e.g., SII-angiotensin II) block agonist stimulated heterotrimeric G protein signaling while promoting β-arrestin signaling. Molecular Cell 2006 24, 643-652DOI: (10.1016/j.molcel.2006.11.007) Copyright © 2006 Elsevier Inc. Terms and Conditions